Husky’s vaccine refrigerator for GP and dental surgeries, hospitals, chemists and clinics is a precision engineered and high-spec unit built with a robust stainless steel outer and hermetically sealed hygienic ABS plastic interior, complete with rounded corners to aid cleaning.
A pre-set electronic temperature controller stores vaccines at 2°–8°C. The fridge also incorporates an audible door open alarm, failed temperature alarm, and a fail-safe secondary back-up digital display thermometer.
The vaccine refrigerator door includes security lock as standard, and the refrigerant used in manufacture is R600, an efficient hydrocarbon refrigerant coolant that is CFC-free and a natural non-greenhouse gas.
Husky is also planning the launch of a domestic model for secure storage at home, which will help keep medicines away from children and other products stored in a household refrigerator.
Husky keeps vaccines cool
Vaccine refrigerator has a stainless steel outer and hermetically sealed interior
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Taking biologic therapies out of the clinic
Read moreHow larger autoinjectors are changing drug delivery device testing
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing]()
How intelligent checkweighers offer improved productivity in pharmaceutical manufacturing
Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance processes and maintain reliable output across demanding production lines
Manufacturing
![Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India]()
Shilpa CDMO invests $50m to expand peptide manufacturing capacity in India
The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at its Raichur campus, expanding its capabilities to meet demand for GLP-1s and increasingly complex peptide therapeutics across oncology and rare diseases
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
![From speed to strategy: how UK life sciences should respond to China’s rise]()
From speed to strategy: how UK life sciences should respond to China’s rise
A group of biotech founders, big pharma leaders, clinical and CMC specialists, and CDMO executives gathered at a recent dinner sponsored by AsymChem to discuss a question now sitting in many boardrooms: what is China’s maturing biopharma ecosystem doing to the global industry, and how should UK companies respond?